Non-Polymer-Based Paclitaxel-Coated Coronary Stents for the Treatment of Patients with De Novo Coronary Lesions: Angiographic Follow-Up of the DELIVER Clinical Trial

Circulation

Volumn 109, Issue 16, 2004, Pages 1948-1954

  Lansky, Alexandra J ^a   Costa, Ricardo A ^a   Mintz, Gary S ^a   Tsuchiya, Yoshihiro ^a   Midei, Mark ^b,g   Cox, David A ^c   O'Shaughnessy, Charles ^d   Applegate, Robert A ^e   Cannon, Louis A ^f   Mooney, Michael ^b,g   Farah, Anthony ^h   Tannenbaum, Mark A ⁱ   Yakubov, Steven ^j   Kereiakes, Dean J ^k   Wong, S Chiu ^l   Kaplan, Barry ^m   Cristea, Ecaterina ^a   Stone, Gregg W ^a   Leon, Martin B ^a   Knopf, William D ⁿ   O'Neill, William W ^o   more..

^a CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^b St Joseph Medical Center   (United States)

^c PRESBYTERIAN HOSPITAL   (United States)

^d EMF Regional Medical Center   (United States)

^e WAKE FOREST BAPTIST HEALTH   (United States)

^f Michigan Cardiovascular Institute   (United States)

^g MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

^h ALLEGHENY GENERAL HOSPITAL   (United States)

ⁱ IOWA HEART CENTER   (United States)

^j RIVERSIDE METHODIST HOSPITAL   (United States)

^k Ohio Heart and Vascular Center   (United States)

^l NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^m NORTH SHORE UNIVERSITY HOSPITAL   (United States)

ⁿ Saint Joseph's Hospital of Atlanta   (United States)

^o WILLIAM BEAUMONT HOSPITAL   (United States)

more..

Author keywords

Angioplasty; Coronary artery disease; Restenosis; Stents; Trials

Indexed keywords

FIBRINOGEN RECEPTOR ANTAGONIST; PACLITAXEL; POLYMER; RAPAMYCIN;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTERY DIAMETER; ARTERY INTIMA PROLIFERATION; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY STENT; DOUBLE BLIND PROCEDURE; DRUG COATING; DRUG ELUTING STENT; DRUG POTENCY; EVALUATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROTUBULE ASSEMBLY; MULTICENTER STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; SMOOTH MUSCLE FIBER; TREATMENT FAILURE; TREATMENT OUTCOME;

COMBINED MODALITY THERAPY; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; CORONARY STENOSIS; DRUG DELIVERY SYSTEMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PACLITAXEL; STENTS; TREATMENT OUTCOME;

EID: 11144357642     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000127129.94129.6F     Document Type: Article

References (32)

1. Serruys PW, de Jaegere P, Kiemeneij F, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease: Benestent Study Group. N Engl J Med. 1994;331:489-495.
2. Fischman DL, Leon MB, Baim DS, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease: Stent Restenosis Study Investigators. N Engl J Med. 1994;331:496-501.
3. Umans VA, Melkert R, Foley DP, et al. Clinical and angiographic comparison of matched patients with successful directional coronary atherectomy or stent implantation for primary coronary artery lesions. J Am Coll Cardiol. 1996;28:637-644.
4. Costa MA, Foley DP, Serruys PW. Restenosis: the problem and how to deal with it. In: Grech ED, Ramsdale DR, eds. Practical Interventional Cardiology. 2nd ed. London, UK: Martin Dunitz; 2002:279-294.
5. Serruys PW, Unger F, Sousa JE, et al. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med. 2001;344:1117-1124.
6. Martinez-Elbal L, Ruiz-Nodar JM, Zueco J, et al. Direct coronary stenting versus stenting with balloon pre-dilatation: immediate and follow-up results of a multicentre, prospective, randomized study: the DISCO trial: Direct Stenting of Coronary Arteries. Eur Heart J. 2002;23:633-640.
7. Eltchaninoff H, Koning R, Tron C, et al. Balloon angioplasty for the treatment of coronary in-stent restenosis: immediate results and 6-month angiographic recurrent restenosis rate. J Am Coll Cardiol. 1998;32:980-984.
8. Dauerman HL, Baim DS, Cutlip DE, et al. Mechanical debulking versus balloon angioplasty for the treatment of diffuse in-stent restenosis. Am J Cardiol. 1998;82:277-284.
9. vow Dahl J, Radke PW, Haager PK, et al. Clinical and angiographic predictors of recurrent restenosis after percutaneous transluminal rotational atherectomy for treatment of diffuse in-stent restenosis. Am J Cardiol. 1999;83:862-867.
10. Teirstein PS, Massullo V, Jani S, et al. Catheter-based radiotherapy to inhibit restenosis after coronary stenting. N Engl J Med. 1997;336:1697-1703.
11. Leon MB, Teirstein PS, Moses JW, et al. Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting. N Engl J Med. 2001;344:250-256.
12. Kuntz RE, Baim DS. Prevention of coronary restenosis. Circulation. 2000;101:2130-2133.
13. Ellis SG, Effron MB, Gold HK, et al. Acute platelet inhibition with abciximab does not reduce in-stent restenosis (ERASER study). Circulation. 1999;100:799-806.
14. Lee CW, Chae JK, Lim HY, et al. Prospective randomized trial of corticosteroids for the prevention of restenosis after intracoronary stent implantation. Am Heart J. 1999; 138:60-63.
15. Serruys PW, Foley DP, Pieper M, et al. The TRAPIST study: a multicentre randomized placebo controlled clinical trial of Trapicil for prevention of restenosis after coronary stenting, measured by 3-D intravascular ultrasound. Eur Heart J. 2001;22:1938-1947.
16. Meurice T, Bauters C, Hermant X, et al. Effect of ACE inhibitors on angiographic restenosis after coronary stenting (PARIS): a randomized, double-blind, placebo-controlled trial. Lancet. 2001;357:1321-1324.
17. Lincoff AM, Topol EJ, Ellis SG. Local drug delivery for the prevention of restenosis: fact, fancy, and future. Circulation. 1994;90:2070-2084.
18. Topol EJ, Serruys PW. Frontiers in interventional cardiology. Circulation. 1998;98:1802-1820.
19. Park SJ, Shim WH, Ho DS, et al. A paclitaxel-eluting stent for the prevention of coronary restenosis. N Engl J Med. 2003;348:1537-1545.
20. Gershlick A, DeScheerder I, Chevalier B, et al. Inhibition of restenosis with a paclitaxel-eluting, polymer-free coronary stent: the European evaLUation of paclitaxel Eluting Stent (ELUTES) Trial. Circulation. 2004;109:487-493.
21. Colombo A, Drzewiecki J, Banning A, et al. Randomized study to assess the effectiveness of slow- and moderate release polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation. 2003 108:r36-r42.
22. Morice MC, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 2002;346:1773-1780.
23. Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003;349:1315-1323.
24. Stone GW, Ellis SG, Cox DA. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med. 2004;350:221-231.
25. van der Giessen WJ, Lincoff AM, Schwartz RS, et al. Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries. Circulation. 1996;94:1690-1697.
26. Suzuki T, Kopia G, Hayashi S, et al. Stent-based delivery of simlimus reduces neointimal formation in a porcine coronary model. Circulation. 2001;104:1188-1193.
27. Lansky AJ, Popma JJ. Qualitative and quantitative angiography. In: Topol EJ, ed. Textbook of Interventional Cardiology. 3rd ed. Philadelphia, Pa: WB Saunders; 1999:725-747.
28. Axel DI, Kunert W, Goggelmann C, et al. Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery. Circulation. 1997;96:636-645.
29. Herdeg C, Oberhoff M, Baumbach A, et al. Local paclitaxel delivery for the prevention of restenosis: biological effects and efficacy in vivo. J Am Coll Cardiol. 2000;35:1969-1976.
30. Kastrati A, Mehilli J, Dirschinger J, et al. Intracoronary Stenting And Angiographic Results: Strut Thickness Effect on Restenosis Outcome (ISAR-STEREO) trial. Circulation. 2001;103:2816-2821.
31. Colombo A, Stankovic G, Moses JW. Selection of coronary stents. J Am Coll Cardiol. 2002;40:1021-1033.
32. Chevalier B, Glatt B, Guyon P, et al. The V-FLEX Plus™ coronary stent. In: Serruys PW, Kutryk MJB, eds. Handbook of Coronary Stents. London, UK: Martin Dunitz; 2000:211-216.